Bellring Brands LLC vs ELF Beauty: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Bellring Brands LLC (BRBR)

Q3 202617 Jun – 11 Aug 2026

▼3

BellRing's profit outlook slashed again on inventory, freight and weak demand

Sales growth questioned as stockpiling, not real demand A law firm is investigating whether BellRing misled investors by calling its sales growth real consumer demand when it was actually customers stocking up, and by downplaying competition. If true, it undermines trust in the company's numbers and could bring legal costs, weighing on the stock.
It questions whether reported sales reflect genuine demand, a core driver of the investment case.
Profit guidance cut twice on inventory and freight costs BellRing lowered its full-year profit forecast to $275-$295 million from $315-$335 million, blaming excess shake-bottle inventory, a bad ingredient from a supplier, and sharply higher freight costs. Profit margins are shrinking, so the stock fell even though sales beat expectations.
This is the main new reason the stock is under pressure: earnings power is falling.
Price increases and new products aim to fix margins Management plans a double-digit price increase on Premier shakes in early 2027, plus cost cuts and two new products to reach new customers. These could restore profits, but price hikes risk scaring off shoppers already facing competition, so the benefit is uncertain.
It shows the company's plan to recover, a real counterweight to the negative profit news.
Valuation reset leaves execution risk unresolved After falling over 50% this year, BellRing trades at 10.2 times forward earnings, well below its historical average. That cheap price may attract buyers, but weak Premier Protein sales momentum and heavy promotions show the company still has to prove it can grow profitably.
It explains why the stock is cheap but not necessarily a bargain, balancing the picture.

July 202617 Jun – 11 Aug 2026

▼3

BellRing's profit outlook slashed again on inventory, freight and weak demand

Sales growth questioned as stockpiling, not real demand A law firm is investigating whether BellRing misled investors by calling its sales growth real consumer demand when it was actually customers stocking up, and by downplaying competition. If true, it undermines trust in the company's numbers and could bring legal costs, weighing on the stock.
It questions whether reported sales reflect genuine demand, a core driver of the investment case.
Profit guidance cut twice on inventory and freight costs BellRing lowered its full-year profit forecast to $275-$295 million from $315-$335 million, blaming excess shake-bottle inventory, a bad ingredient from a supplier, and sharply higher freight costs. Profit margins are shrinking, so the stock fell even though sales beat expectations.
This is the main new reason the stock is under pressure: earnings power is falling.
Price increases and new products aim to fix margins Management plans a double-digit price increase on Premier shakes in early 2027, plus cost cuts and two new products to reach new customers. These could restore profits, but price hikes risk scaring off shoppers already facing competition, so the benefit is uncertain.
It shows the company's plan to recover, a real counterweight to the negative profit news.
Valuation reset leaves execution risk unresolved After falling over 50% this year, BellRing trades at 10.2 times forward earnings, well below its historical average. That cheap price may attract buyers, but weak Premier Protein sales momentum and heavy promotions show the company still has to prove it can grow profitably.
It explains why the stock is cheap but not necessarily a bargain, balancing the picture.

Latest17 Jun – 11 Aug 2026

▼3

BellRing's profit outlook slashed again on inventory, freight and weak demand

Sales growth questioned as stockpiling, not real demand A law firm is investigating whether BellRing misled investors by calling its sales growth real consumer demand when it was actually customers stocking up, and by downplaying competition. If true, it undermines trust in the company's numbers and could bring legal costs, weighing on the stock.
It questions whether reported sales reflect genuine demand, a core driver of the investment case.
Profit guidance cut twice on inventory and freight costs BellRing lowered its full-year profit forecast to $275-$295 million from $315-$335 million, blaming excess shake-bottle inventory, a bad ingredient from a supplier, and sharply higher freight costs. Profit margins are shrinking, so the stock fell even though sales beat expectations.
This is the main new reason the stock is under pressure: earnings power is falling.
Price increases and new products aim to fix margins Management plans a double-digit price increase on Premier shakes in early 2027, plus cost cuts and two new products to reach new customers. These could restore profits, but price hikes risk scaring off shoppers already facing competition, so the benefit is uncertain.
It shows the company's plan to recover, a real counterweight to the negative profit news.
Valuation reset leaves execution risk unresolved After falling over 50% this year, BellRing trades at 10.2 times forward earnings, well below its historical average. That cheap price may attract buyers, but weak Premier Protein sales momentum and heavy promotions show the company still has to prove it can grow profitably.
It explains why the stock is cheap but not necessarily a bargain, balancing the picture.

ELF Beauty Inc (ELF)

Q3 202622 Jun – 23 Jul 2026

▲3

e.l.f. Beauty cuts prices, adds hair care, and expands Rhode to revive growth

Price cuts spark strong consumer response e.l.f. cut prices on select items, like a skin tint from $18 to $14, driving an 85% jump in unit sales. This reverses earlier price hikes that had hurt demand. If shoppers keep responding, sales and profits could rise, lifting the stock.
Shows a direct, new action to fix weak demand and its early success.
First hair care line launches with strong pilot results e.l.f. Hair, a six-product line, expands the company into a new category. A pilot run saw 96% positive sentiment and 65% of buyers new to the brand. This opens a new market and could add sales growth, supporting a higher stock price.
New product category is a fresh growth driver not previously reported.
Rhode and Naturium drive skin care growth Rhode net sales grew over 80% to about $390 million, and Naturium roughly doubled to nearly $250 million. Skin care is now 23% of sales, up from 9% three years ago. These brands are fueling growth and could lift the stock as they expand.
Highlights the new growth engines that are offsetting core brand weakness.
Valuation low but turnaround uncertain The stock trades at 19 times earnings, far below its usual 52 times, after a 48% drop over the past year. A $58.5 million tariff refund and June's 32% rally helped, but profit fell 59% last quarter and guidance depends on a second-half rebound. Cheap valuation may attract buyers, but risks remain.
Captures the key counterweight: low price versus weak earnings and uncertain recovery.

July 202622 Jun – 23 Jul 2026

▲3

e.l.f. Beauty cuts prices, adds hair care, and expands Rhode to revive growth

Price cuts spark strong consumer response e.l.f. cut prices on select items, like a skin tint from $18 to $14, driving an 85% jump in unit sales. This reverses earlier price hikes that had hurt demand. If shoppers keep responding, sales and profits could rise, lifting the stock.
Shows a direct, new action to fix weak demand and its early success.
First hair care line launches with strong pilot results e.l.f. Hair, a six-product line, expands the company into a new category. A pilot run saw 96% positive sentiment and 65% of buyers new to the brand. This opens a new market and could add sales growth, supporting a higher stock price.
New product category is a fresh growth driver not previously reported.
Rhode and Naturium drive skin care growth Rhode net sales grew over 80% to about $390 million, and Naturium roughly doubled to nearly $250 million. Skin care is now 23% of sales, up from 9% three years ago. These brands are fueling growth and could lift the stock as they expand.
Highlights the new growth engines that are offsetting core brand weakness.
Valuation low but turnaround uncertain The stock trades at 19 times earnings, far below its usual 52 times, after a 48% drop over the past year. A $58.5 million tariff refund and June's 32% rally helped, but profit fell 59% last quarter and guidance depends on a second-half rebound. Cheap valuation may attract buyers, but risks remain.
Captures the key counterweight: low price versus weak earnings and uncertain recovery.

Latest22 Jun – 23 Jul 2026

▲3

e.l.f. Beauty cuts prices, adds hair care, and expands Rhode to revive growth

Price cuts spark strong consumer response e.l.f. cut prices on select items, like a skin tint from $18 to $14, driving an 85% jump in unit sales. This reverses earlier price hikes that had hurt demand. If shoppers keep responding, sales and profits could rise, lifting the stock.
Shows a direct, new action to fix weak demand and its early success.
First hair care line launches with strong pilot results e.l.f. Hair, a six-product line, expands the company into a new category. A pilot run saw 96% positive sentiment and 65% of buyers new to the brand. This opens a new market and could add sales growth, supporting a higher stock price.
New product category is a fresh growth driver not previously reported.
Rhode and Naturium drive skin care growth Rhode net sales grew over 80% to about $390 million, and Naturium roughly doubled to nearly $250 million. Skin care is now 23% of sales, up from 9% three years ago. These brands are fueling growth and could lift the stock as they expand.
Highlights the new growth engines that are offsetting core brand weakness.
Valuation low but turnaround uncertain The stock trades at 19 times earnings, far below its usual 52 times, after a 48% drop over the past year. A $58.5 million tariff refund and June's 32% rally helped, but profit fell 59% last quarter and guidance depends on a second-half rebound. Cheap valuation may attract buyers, but risks remain.
Captures the key counterweight: low price versus weak earnings and uncertain recovery.